Drug-Disease Severity and Target-Disease Severity Interaction Networks in COVID-19 Patients
Drug interactions with other drugs are a well-known phenomenon. Similarly, however, pre-existing drug therapy can alter the course of diseases for which it has not been prescribed. We performed network analysis on drugs and their respective targets to investigate whether there are drugs or targets w...
Saved in:
Main Authors: | Verena Schöning (Author), Felix Hammann (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Polypharmacy in chronic liver disease patients: Implications for disease severity, drug-drug interaction, and quality of life
by: Juveriya Farooq, et al.
Published: (2023) -
Modeling of SARS-CoV-2 Treatment Effects for Informed Drug Repurposing
by: Charlotte Kern, et al.
Published: (2021) -
Periodontal disease severity in patients with long COVID and non-COVID-19
by: Marie Louisa, et al.
Published: (2024) -
Vitamin D and disease severity in coronavirus disease 19 (COVID-19)
by: G. Adami, et al.
Published: (2021) -
Prediction of COVID-19 Patients at High Risk of Progression to Severe Disease
by: Zhenyu Dai, et al.
Published: (2020)